BG104654A - Method for treatment of chronic obstructive pulmonary disease (copd) - Google Patents

Method for treatment of chronic obstructive pulmonary disease (copd)

Info

Publication number
BG104654A
BG104654A BG104654A BG10465400A BG104654A BG 104654 A BG104654 A BG 104654A BG 104654 A BG104654 A BG 104654A BG 10465400 A BG10465400 A BG 10465400A BG 104654 A BG104654 A BG 104654A
Authority
BG
Bulgaria
Prior art keywords
copd
treatment
pulmonary disease
chronic obstructive
obstructive pulmonary
Prior art date
Application number
BG104654A
Other languages
Bulgarian (bg)
English (en)
Inventor
Siegfried Christensen
Theodore Torphy
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of BG104654A publication Critical patent/BG104654A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)
BG104654A 1998-01-07 2000-08-01 Method for treatment of chronic obstructive pulmonary disease (copd) BG104654A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7071898P 1998-01-07 1998-01-07
US10690898P 1998-10-28 1998-10-28
PCT/US1999/000214 WO1999034798A1 (en) 1998-01-07 1999-01-06 Method for treating copd

Publications (1)

Publication Number Publication Date
BG104654A true BG104654A (en) 2001-04-30

Family

ID=26751429

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104654A BG104654A (en) 1998-01-07 2000-08-01 Method for treatment of chronic obstructive pulmonary disease (copd)

Country Status (34)

Country Link
US (1) US6369108B1 (de)
EP (1) EP1051172B1 (de)
JP (1) JP2003522095A (de)
KR (1) KR100555824B1 (de)
CN (1) CN1291891A (de)
AP (1) AP2000001859A0 (de)
AR (1) AR014411A1 (de)
AT (1) ATE285234T1 (de)
AU (1) AU752497B2 (de)
BG (1) BG104654A (de)
BR (1) BR9906803A (de)
CA (1) CA2317720A1 (de)
DE (1) DE69922786T2 (de)
DZ (1) DZ2703A1 (de)
EA (1) EA006382B1 (de)
EG (1) EG23945A (de)
ES (1) ES2234234T3 (de)
HK (1) HK1033551A1 (de)
HU (1) HUP0100888A3 (de)
ID (1) ID26164A (de)
IL (1) IL137104A0 (de)
MA (1) MA26592A1 (de)
MY (1) MY133014A (de)
NO (1) NO20003481L (de)
NZ (1) NZ505521A (de)
OA (1) OA11443A (de)
PE (1) PE20000231A1 (de)
PL (1) PL341667A1 (de)
PT (1) PT1051172E (de)
SI (1) SI1051172T1 (de)
SK (1) SK285149B6 (de)
TR (1) TR200001819T2 (de)
UY (1) UY25338A1 (de)
WO (1) WO1999034798A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DZ3019A1 (fr) 1999-03-01 2005-05-20 Smithkline Beecham Corp Utilisation d'un inhibiteur de pde4 dans la préparation d'un médicament contre la copd.
AR024076A1 (es) * 1999-05-25 2002-09-04 Smithkline Beecham Corp Sales de cis-[4-ciano-4-(3-ciclopentiloxi-4-metoxifenil) ciclohexan-1-carboxilato]
CZ2002460A3 (cs) * 1999-08-10 2002-06-12 Smithkline Beecham Corporation 1,4-Substituované 4,4-diarylcyklohexany
WO2001043692A2 (en) * 1999-12-15 2001-06-21 Smithkline Beecham Corporation SALTS OF Cis-4-CYANO-4-[3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]CYCLOHEXANE-1-CARBOXYLIC ACID
EP2258689A1 (de) 2000-03-16 2010-12-08 Biolipox AB Benzylierte PDE4-Inhibitoren
DE10245153A1 (de) * 2002-09-27 2004-04-15 Infineon Technologies Ag Integrierter Feldeffekttransistor mit zwei Steuerbereichen, Verwendung dieses Feldeffekttranistors und Herstellungsverfahren
WO2006129164A1 (en) 2005-05-31 2006-12-07 Pfizer Japan Inc. Substituted aryloxy-n-bicyclomethyl acetamide compounds as vr1 antagonists
KR101608702B1 (ko) * 2007-06-05 2016-04-04 사노피 디(헤테로)아릴사이클로헥산 유도체, 이들의 제조방법, 이들의 용도 및 이들을 포함하는 약제학적 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0633771A4 (en) * 1992-04-02 1995-02-22 Smithkline Beecham Corporation Compounds.
WO1993019749A1 (en) * 1992-04-02 1993-10-14 Smithkline Beecham Corporation Compounds useful for treating allergic and inflammatory diseases
GB9525262D0 (en) * 1995-12-11 1996-02-07 Bayer Ag Heterocyclylcarbonyl substituted benzofuranyl-ureas

Also Published As

Publication number Publication date
CA2317720A1 (en) 1999-07-15
CN1291891A (zh) 2001-04-18
AP2000001859A0 (en) 2000-09-30
SI1051172T1 (en) 2005-06-30
HUP0100888A3 (en) 2003-07-28
AU2106099A (en) 1999-07-26
EA006382B1 (ru) 2005-12-29
EG23945A (en) 2008-01-22
SK10232000A3 (sk) 2001-01-18
MA26592A1 (fr) 2004-12-20
DZ2703A1 (fr) 2003-09-01
MY133014A (en) 2007-10-31
HK1033551A1 (en) 2001-09-07
ES2234234T3 (es) 2005-06-16
DE69922786T2 (de) 2005-06-23
KR20010033909A (ko) 2001-04-25
DE69922786D1 (de) 2005-01-27
KR100555824B1 (ko) 2006-03-03
OA11443A (en) 2004-04-28
NO20003481L (no) 2000-08-25
JP2003522095A (ja) 2003-07-22
IL137104A0 (en) 2001-06-14
EP1051172A4 (de) 2002-08-14
ATE285234T1 (de) 2005-01-15
SK285149B6 (sk) 2006-07-07
PT1051172E (pt) 2005-03-31
EA200000740A1 (ru) 2001-02-26
EP1051172A2 (de) 2000-11-15
AU752497B2 (en) 2002-09-19
NO20003481D0 (no) 2000-07-06
EP1051172B1 (de) 2004-12-22
UY25338A1 (es) 2001-08-27
ID26164A (id) 2000-11-30
AR014411A1 (es) 2001-02-28
NZ505521A (en) 2004-02-27
PE20000231A1 (es) 2000-03-24
US6369108B1 (en) 2002-04-09
TR200001819T2 (tr) 2000-11-21
HUP0100888A2 (hu) 2001-08-28
BR9906803A (pt) 2002-05-28
PL341667A1 (en) 2001-04-23
WO1999034798A1 (en) 1999-07-15

Similar Documents

Publication Publication Date Title
NZ330216A (en) Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and use in treatment of atherosclerosis
HU9501569D0 (en) Oxalyl-amino-benzo-furane- and benzo-thienyl-derivatives, process for producing them and pharmaceutical compositions containing them
NO971520L (no) Fremgangsmåte for hemming av tilstander forbundet med neuropeptid Y
WO2001081312A3 (en) Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
MX9803809A (es) Inhibidores de hidroxamato de bifenilo de metaloproteinasas de matriz.
WO2003024391A3 (en) Treatment and prevention of mucositis in cancer patients
CA2283399A1 (en) Pyridazinones as inhibitors of cyclooxygenase-2
NO20000093D0 (no) (+)-Norcisaprid nyttig for 5-HT3 og 5-HT4-medierte forstyrrelser
AU7579194A (en) Methods for inhibiting angiogenisis and angiogenic diseases
BG104654A (en) Method for treatment of chronic obstructive pulmonary disease (copd)
IL126137A0 (en) New benzofuranone derivatives and a method for producing them
HU9902668D0 (en) Compounds with growth hormone releasing properties
CA2218887A1 (en) Piperazino derivatives as neurokinin antagonists
NZ502366A (en) Aminoethylphenoxyacetic acid derivatives and drugs for pain remission and calculi removal promotion in urinary lithiasis
AP2002002496A0 (en) Method and compositions for treating pulmonary diseases.
WO2003053352A3 (en) Therapeutic compounds for treating dyslipidemic conditions
SE9702716D0 (sv) Substituted phenylazacycloalkanes in the treatment of cognitive disorders
GR3036241T3 (en) METHOD OF TREATMENT OF CHRONIC PROSTATITIS WITH 17-g(b)-N-MONOSUBSTITUTED-CARBAMOYL-4-AZA-5-g(a)-ANDROST-1-EN-3-ONES.
IL156768A0 (en) Process for preparing (+/-) trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidine
EP0378146A3 (de) Polyamin-Derivate als antineoplastische Mittel
AU2287499A (en) Azetidinecarboxamide derivatives for treating cns disorders
CA2301590A1 (en) 2-aminopyridines as inhibitors of cyclooxygenase-2
MX9604692A (es) Derivados de quinoxalina para el tratamiento de tinnitus.
AU2178099A (en) Azetidinecarboxamide derivatives for treating cns disorders
HK1052923A1 (en) Method for producing chiral compounds.